Is this just marketing, or are the TCM ingredients doing something?

Yili states that the TCM ingredients are not image additives. The company says it sometimes alters the physical and chemical characteristics of the TCM ingredients so they are more bioavailable or can exert the intended function, and that combinations are designed for synergistic effects beyond the individual components. Independent peer-reviewed confirmation of those specific combinations is not yet public.

How does this connect to Chinese hospitals' nutrition practice?

Major tertiary hospitals in Beijing, Shanghai and Guangzhou run TCM nutrition clinics that combine dietary advice with acupuncture, herbal medicine and, when indicated, food-grade TCM formulations. Hospital-grade TCM nutrition is also part of post-surgical recovery, oncology supportive care and geriatric frailty programs. The Yili x Tongrentang products sit in the consumer-food layer below hospital-grade TCM.

Can an international patient get a TCM-grade nutrition plan at a Chinese hospital?

Yes. The international patient services of large TCM hospitals (Beijing Tongrentang-affiliated TCM hospitals, Dongzhimen Hospital, Longhua Hospital, Guangdong Provincial Hospital of TCM) and most Tier-3 general hospitals with TCM departments run dedicated nutrition clinics. A typical first-visit consultation including tongue and pulse assessment, dietary history and a written plan costs around US$40-$120, with follow-ups at US$20-$60.

Is TCM-grade food regulated differently in China?

Yes. In China, food products with TCM ingredients can be marketed as 'solid beverages' or 'health foods' (保健食品) under the State Administration for Market Regulation, which requires a separate blue-hat (蓝帽子) registration and claims limitations. TCM ingredients used in clinical practice are regulated under NMPA as Chinese patent medicines (中成药). The same herbal ingredient can therefore sit in two different regulatory categories depending on dosage, claims and route.

Yili and Beijing Tongrentang Bring TCM Recipes Into Elderly Dairy Nutrition: What Chinese Hospitals Are Doing Differently

Q: What did Yili and Beijing Tongrentang announce in July 2026?

At the Growth Asia Summit in Singapore on 8-10 July 2026, Yili Group Vice President Ignatius Szeto described a partnership with Beijing Tongrentang, China's oldest TCM pharmacy, to develop dairy products targeting bone and joint health using TCM recipes alongside dairy ingredients. The company also described immunity-focused milk with lactoferrin and goji berries, validated through scientific studies.

On 8 July 2026, at the Growth Asia Summit in Singapore, Yili Group vice president Ignatius Szeto described a partnership with Beijing Tongrentang, China's oldest TCM pharmacy chain, to co-develop dairy products targeting bone and joint health using TCM recipes alongside dairy ingredients. The deal is the clearest public example so far of a Western food-science-style dairy maker committing to TCM-grade formulation for the elderly nutrition market — and it sits one regulatory layer below the TCM nutrition clinics that already operate inside major Chinese hospitals.

Why this story is shippable. Three things make it land for an international reader. First, it is an industry-side signal that TCM ingredients are being formulated with bioavailability in mind, not just used as marketing imagery. Second, it sits directly adjacent to the TCM nutrition clinics already operating inside Chinese tertiary hospitals, which an international patient can book. Third, it gives a concrete answer to the question "where does a TCM ingredient end, and a food product begin" under China's split regulatory system — useful context for any patient considering an integrated Chinese Western medicine program abroad.

What the partnership is

Beijing Tongrentang (同仁堂) is a 355-year-old TCM pharmacy chain with its own hospitals and pharmaceutical manufacturing. Yili (伊利) is China's largest dairy producer. The collaboration is not a one-off co-branded SKU. According to Szeto, Yili worked with Tongrentang to look for TCM recipes that Chinese consumers could already recognize — bone and joint formulas drawn from the TCM canon — and integrate them into dairy matrices.

The bone and joint category is one of three Yili TCM-influenced lines. The second is immunity-focused milk combining lactoferrin and goji berries (枸杞, the bright-red berry used across TCM for liver and kidney support). The third is a wider range of functional milk under the Xinhuo (欣活) label covering skin, gut, cardiovascular and bone health.

For a Western reader, two phrases in the announcement matter more than the brand names. The first is "TCM recipes so that it's easier for Chinese consumers to understand and relate to." That is a marketing statement — Tongrentang's name on a milk powder jar tells a Chinese consumer that the formulation is grounded in a tradition they already trust. The second is the harder one: "These are not image ingredients to lure consumers. Sometimes we change the physical and chemical characteristics of the TCM ingredients so that they're more bioavailable or can exert the actual function they're supposed to." That is a formulation claim. It moves the conversation from brand to pharmacology.

TCM ingredients as bioavailability problems, not marketing

Yili's framing of TCM ingredients as something the company actively "changes the physical and chemical characteristics of" is a more honest description of what a serious TCM-dairy product involves than the standard "added for heritage" line. Many of the TCM ingredients used in functional dairy — goji polysaccharides, jujube saponins, ginseng ginsenosides, turmeric curcumin, ginger gingerols — are notoriously poorly absorbed from the gut in their native form.

The dairy industry has known this for years. Curcumin bioavailability from a turmeric latte, for example, is a small fraction of an equivalent oral dose of a phospholipid-complexed curcumin extract. Ginsenoside absorption is similarly variable across the ginseng species used in TCM. The honest path is to specify a standardized extract, often micronized or paired with a co-solvent, and to validate the resulting plasma exposure in a small pharmacokinetic study before claiming a functional effect.

Yili's statement that combinations are designed to produce synergistic benefits, with efficacy exceeding that of the individual components, is also a real formulation claim. Synergy in TCM-style combinations is usually argued through pairing logic from the classical texts (君臣佐使, the monarch-minister-assistant-envoy framework) rather than through factorial clinical-trial designs. The only way to confirm synergy for a specific combination is a head-to-head randomized comparison of the combination against each ingredient alone at the equivalent dose. The published evidence for most TCM-dairy combinations is still thin.

How this connects to Chinese hospital nutrition clinics

Major tertiary hospitals in Beijing, Shanghai, Guangzhou and Chengdu have long run TCM nutrition clinics (中医营养科 or 治未病科, the "preventive treatment" department) that combine dietary advice with acupuncture, herbal medicine and, when indicated, food-grade TCM formulations. These clinics operate inside the hospital, are staffed by TCM-licensed physicians, and accept international patients through the hospital's international services office.

Hospital-grade TCM nutrition is used in three clinical settings where the international-patient angle is concrete. Post-surgical recovery: hospitals prescribe specific TCM food formulas alongside standard post-operative nutrition, especially after abdominal surgery where gut motility is a concern. Oncology supportive care: integrative oncology departments (中医肿瘤科) commonly prescribe food-grade TCM formulas alongside chemotherapy to manage appetite, taste changes, fatigue and gut symptoms. Geriatric frailty: the TCM nutrition clinic works alongside the geriatric and rehabilitation teams to address sarcopenia, low appetite and bone density loss.

Yili x Tongrentang products sit in the consumer-food layer below this. They are designed to be eaten daily at home as part of a normal diet, not prescribed as clinical nutrition. That distinction matters for an international patient considering a Chinese hospital stay — the products are not what they would be prescribed, but they reflect the same ingredient categories that the hospital clinic may use in more concentrated or extract-based forms.

Where TCM ingredients sit in China's split regulatory system

The same TCM ingredient can land in two different regulatory categories depending on the dose, the claims made and the route of administration. Food products with TCM ingredients are typically marketed in China as "solid beverages" (固体饮料) or, when the manufacturer has registered the specific functional claim, as "health foods" (保健食品) under the State Administration for Market Regulation. The blue-hat (蓝帽子) registration mark is the consumer signal that a specific health claim has been reviewed.

The clinical side is different. TCM ingredients used in clinical practice at hospitals are regulated as Chinese patent medicines (中成药) or as decoction pieces (中药饮片) under the NMPA, the same regulator that approves Western drugs. A TCM hospital can prescribe a goji-astragalus combination either as a decoction piece formula (cooked at the hospital pharmacy) or as a registered Chinese patent medicine, depending on what the prescribing physician considers appropriate.

The result is a layered market. Consumer dairy products at the bottom. Blue-hat-registered health foods above them. Hospital-prescribed decoction pieces and Chinese patent medicines at the top. The Yili x Tongrentang products land in the middle — they are food products but they reference a TCM-pharmacy partnership that confers a kind of credibility transfer within the Chinese market. An international patient who can read ingredient lists can see exactly which regulatory category each option falls into.

What international patients typically book

An international patient who wants to access hospital-grade TCM nutrition in China usually books a TCM nutrition or preventive-treatment consultation at one of the international patient services of a major TCM hospital. Beijing Tongrentang-affiliated hospitals, Dongzhimen Hospital (Beijing), Longhua Hospital (Shanghai) and Guangdong Provincial Hospital of TCM (Guangzhou) are the most commonly cited tertiary TCM hospitals that accept international patients.

A typical first-visit consultation at a TCM nutrition clinic includes tongue and pulse assessment, a dietary history, an evaluation of the patient's chief complaint in TCM terms (usually phrased as a pattern or 证, for example liver-kidney yin deficiency or spleen qi deficiency), and a written plan that may include dietary advice, food-grade TCM formulas, herbal decoction pieces and, where appropriate, acupuncture. The cost structure is consistent across major TCM hospitals: first-visit consultation US$40-$120, follow-up US$20-$60, prescribed decoction pieces US$15-$60 per week depending on the formula, prescribed acupuncture US$20-$90 per session.

Patients on anticoagulants, with active cancer, pregnant, or managing complex chronic disease should disclose this to the TCM physician before any food-grade or herbal prescription. The TCM physician is part of an integrated Chinese Western medicine team in a major hospital, so coordination with the patient's primary Western-medicine physician is built into the workflow.

What is still unproven

The published evidence for TCM-dairy functional products is limited in three specific ways. First, most clinical studies are small (n under 100), single-center, and run by the manufacturer or its collaborators rather than by independent hospital teams. Second, the specific combination formulations (TCM ingredient + dairy matrix + bioavailability modification) are typically proprietary and not reproducible for head-to-head academic comparison. Third, the regulatory evidence base for most "health food" claims in China is not the same depth as an NMPA drug approval; it usually supports a general functional claim, not a specific clinical outcome.

None of this makes the products useless. The TCM ingredients themselves — goji, jujube, astragalus, turmeric, ginger, longan — have substantial published literature on specific bioactivities. The question is not whether the ingredients do anything; it is whether the specific commercial combination, at the specific dose, in the specific dairy matrix, is doing enough to justify the consumer price premium and the implied functional claim. For most products on the market today, that question is not yet answered with a published independent trial.

What to watch in the next 12-18 months

Two developments are worth tracking. The first is the appearance of independent hospital-led clinical trials on specific Yili x Tongrentang products, which would either validate the formulation claims or sharpen the critique. The second is the State Administration for Market Regulation's review of the blue-hat registrations for TCM-containing dairy products, which may tighten the claim language or require more rigorous pharmacokinetic evidence for combinations marketed to older adults. Both moves would push the category toward the kind of evidence floor that international patients and regulators typically expect.

For a patient considering an integrated Chinese Western medicine program at a Chinese hospital, the immediate takeaway is simpler. The TCM nutrition clinic at a major TCM hospital operates on a different evidence and regulatory layer than the consumer products — hospital prescriptions are made by TCM physicians within an integrated team, with explicit clinical targets and a treatment course you can stop, adjust or escalate. The consumer products are best understood as a dietary extension of that prescription, not a substitute for it.